Low-risk of NSF with Dotarem (Gd-DOTA).
In a study presented in ECR 2011 independent prospective study supported by agencies in France have validated the low-risk status of the contrast agent Dotarem (Gd-DOTA). Detailed report on Diagnostic Imaging
Low-risk of NSF with Dotarem (Gd-DOTA).
![]()
Reviewed by Sumer Sethi
on
Saturday, March 05, 2011
Rating:
Sumer Sethi
Unique blend of academic excellence and entrepreneurship, heading leading firms in India- Teleradiology Providers, pioneering company providing teleradiology services and DAMS (Delhi Academy of Medical Sciences) Premier test preparation institute in India for MD/MS/MCI preparation. He has also been an invited faculty member at various conferences, including Teleradiology in IRIA 2008 and 2011, Hospital Build Middle East, Congress of the Brain Tumor Radiology in Neuro-oncology Society. Dr. Sethi is Editor-in-Chief of Internet Journal of Radiology. He has a keen interest in Web 2.0 technologies and in maintaining his famous radiology blog, which has been featured in multiple international journals.
No comments:
Post a Comment